TrillaMed operates as a verified Service-Disabled Veteran-Owned Small Business (SDVOSB) specializing in medical supply and pharmaceutical distribution to federal healthcare facilities [2]. The company's leadership combines extensive military experience, including Special Operations backgrounds, with deep medical industry expertise to serve over 700 federal medical facilities globally for the Department of Defense and Department of Veterans Affairs [1] [4].
The organization maintains comprehensive federal supply capabilities through multiple contract vehicles and vendor networks, supported by an EDI-compliant portal and full-service distribution infrastructure. Their core operational strengths include:
- CONUS/OCONUS Coverage with full Prime Vendor Network capabilities
- Active DEA and State Pharmaceutical licensing
- Current System for Award Management (SAM) registration
- CVE-Verified SDVOSB status [2]
TrillaMed's federal contracting portfolio encompasses major standardization initiatives and enterprise-wide agreements, including a significant $125M DoD medical logistics agreement for IV catheters serving CONUS, OCONUS, European, and Pacific treatment facilities [3]. The company maintains several key contract vehicles:
- FSS Medical/Surgical Schedule: #36F79720D0041
- FSS Pharmaceutical Schedule: #36F79722D0121
- GSA Multiple Award Schedule: #GS-07F-077CA
- DAPA Med/Surg Contract: #SP0200-14-H 0017
- ECAT: #SPE2D1-21-D-7004 [1]
Notable program achievements demonstrate the company's broad capabilities in healthcare technology and medical supply:
- VA Strategic Acquisition Center GE Healthcare Vital Signs Monitoring Systems contract ($2.3M)
- Fort Harrison VA Medical Center Mobile MRI and PET/CT Services contract ($4.25M)
- Ann Arbor VAMC physiological monitoring system project ($4.9M)
- H.H. McGuire VA Medical Center 5-year radiopharmaceuticals contract ($4.3M) [3]
Recent developments highlight TrillaMed's continued growth and innovation in healthcare technology partnerships. The company received the 2024 Molnlycke "Embrace Partnership" award for clinical support excellence [1] and established a strategic partnership with American Nitrile to provide US-made medical gloves to government customers [2].
Additional strategic implementations include:
- RapidAI neuroimaging stroke software across federal healthcare facilities [5]
- Expanded sterile container solutions through Aesculap partnership [6]
- Comprehensive pharmacy automation capabilities via Omnicell partnership [7]
The company maintains rigorous compliance standards and operational identifiers:
- CAGE Code: 56FN2
- SAM UEI: GW9FLBWB5625
- DUNS: 82-812-6321
- EIN: 37-1571672 [2]